Most Recent
A class action against Allergan over recalled breast implants has asked a court to slash parts of the US pharma company’s defence, saying they are "incoherent".
The Commonwealth Bank has avoided a separate hearing over its cross-appeal in shareholder class actions that have reached the High Court.
Scenic Tours Australia has denied it provided services to international passengers, in a class action over a 2018 European cruise where river levels dropped so low they became impassable.
The judge overseeing class actions against Hyundai and Kia has taken the parties to task over lack of progress in the cases, calling them out for “paying lip service” to the obligation to proceed expeditiously.
CBA plans to file a cross-appeal in the class actions before the High Court, contending the shareholders -- who argue they should have won their loss case -- failed to establish disclosure breaches at the threshold.
Class action settlements hit major milestones last year, with the year’s largest settlements totalling $1.6 billion and one case resolving for a historic $548.5 million.
A judge has allowed a shareholder class action over the collapse of asset manager Blue Sky to bring insider trading claims against several short sellers, as well as brokers Credit Suisse and Argonaut Securities.
The judge overseeing a class action alleging Sony used restrictive trade practices to block competition with its Playstation store has told the applicant to get “a bigger team” on the slow-moving case.
Wealth manager Colonial First State Investments and insurer AIA have reached a $140 million settlement in a long-running class action alleging 700,000 superannuation members were charged inflated premiums on insurance products linked to former owner CBA.
Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.